Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davidson

Showing results (271-280 of 358) with videos related to

Pageof 36
Sort By:
Schizophrenia Bulletin|February 25, 2022
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
Circulation|January 21, 2004
Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart StudyLyle G Best, Michael Davidson, Kari E North, et al.
Bone|August 4, 2025
Prevalent vertebral fracture is associated with incident cardiovascular disease events in older individuals referred for bone densitometryJohn T Schousboe, Barret A Monchka, J Michael Davidson, et al.
Psychological Medicine|March 5, 2019
Understanding the association between advanced paternal age and schizophrenia and bipolar disorderMark Weiser, Daphna Fenchel, Or Frenkel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
Discontinuity in the genetic and environmental causes of the intellectual disability spectrumAbraham Reichenberg, Martin Cederlöf, Andrew McMillan, et al.
The Journal of Infectious Diseases|September 17, 2002
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitisMichael Davidson, Yuan-I Min, Janet T Holbrook, et al.
Schizophrenia Research|April 22, 2006
Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based studyAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
Toxics|October 26, 2022
Biokinetics and Internal Dosimetry of Tritiated Steel ParticlesRachel Smith, Michele Ellender, Chang Guo, et al.
Archives of General Psychiatry|December 7, 2005
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophreniaAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
Schizophrenia Bulletin Open|November 6, 2024
Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled TrialLiron Saporta-Wiesel, Ruth Feldman, Linda Levi, et al.
Pageof 36

Showing results (271-280 of 358) with videos related to

Sort By:
Pageof 36
Schizophrenia Bulletin|February 25, 2022
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
Circulation|January 21, 2004
Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart StudyLyle G Best, Michael Davidson, Kari E North, et al.
Bone|August 4, 2025
Prevalent vertebral fracture is associated with incident cardiovascular disease events in older individuals referred for bone densitometryJohn T Schousboe, Barret A Monchka, J Michael Davidson, et al.
Psychological Medicine|March 5, 2019
Understanding the association between advanced paternal age and schizophrenia and bipolar disorderMark Weiser, Daphna Fenchel, Or Frenkel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
Discontinuity in the genetic and environmental causes of the intellectual disability spectrumAbraham Reichenberg, Martin Cederlöf, Andrew McMillan, et al.
The Journal of Infectious Diseases|September 17, 2002
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitisMichael Davidson, Yuan-I Min, Janet T Holbrook, et al.
Schizophrenia Research|April 22, 2006
Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based studyAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
Toxics|October 26, 2022
Biokinetics and Internal Dosimetry of Tritiated Steel ParticlesRachel Smith, Michele Ellender, Chang Guo, et al.
Archives of General Psychiatry|December 7, 2005
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophreniaAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
Schizophrenia Bulletin Open|November 6, 2024
Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled TrialLiron Saporta-Wiesel, Ruth Feldman, Linda Levi, et al.
Pageof 36